netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Emerging Vision Scientists Visit Capitol Hill

On September 15, the National Alliance for Eye and Vision Research (NAEVR) held its Advocacy Day, supported by Research to Prevent Blindness (RPB), in which 22 emerging vision scientists conducted 50 Capitol Hill visits to discuss their work and champion the need for continued federal funding for critical vision research.

Emerging vision scientists visit the office of Senator Kirsten Gillibrand

Emerging vision scientists and RPB visit the office of Senator Kirsten Gillibrand 

NAEVR's message that "research does not have a pause button" was well received by congressional staff and the eight members of Congress who met directly with the emerging vision scientists. RPB President Brian Hofland, PhD, accompanied several of the emerging vision scientists on their visits with congressional staff, and stressed the need to fund young researchers through both foundations and non-profits (such as RPB) and federal grants.

The young researchers appreciated the opportunity to speak about their work in a political forum. "Personally, I was quite enlightened by these visits in gaining an understanding of the nuts and bolts of how science policy and funding decisions are made at the government level. I feel that this experience helped me to better develop skills to 'sell research' to non-scientists who play a critical role in funding vision research," said Daniel Chao, MD, PhD, from the University of California San Diego.

Emerging vision scientists at AVER Congressional reception

Emerging vision scientists attend the AVER Congressional reception 

Prior to going to the Hill, on September 14 the emerging vision scientists displayed posters of their research at an evening Congressional reception hosted by the Alliance for Eye and Vision Research (AVER, which is NAEVR's associated non-profit educational organization) at which National Eye Institute Director Paul Sieving, MD, PhD, spoke and members of Congress has a chance to interact with the young researchers.

On September 28, just weeks after Advocacy Day, Congress passed a short-term Continuing Resolution that funds the government through the end of 2016--one of the requests NAEVR, RPB and the emerging vision scientists made at their visits. They also advocated for Congressional representatives to return following the election in November to complete 2017 appropriations, including a $2 billion National Institutes of Health funding increase to $34.1 billion.

 

 

 

Related News: Top Story

Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine

Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.

Read More

 

RPB and Partners Award $1.2 Million In Grants for Novel AMD Research

Four new grantees received the Catalyst Awards for Innovative Research Approaches for AMD.

Read More

 

The Career Development Award Turns 30: Celebrating a Generation of Support for Early-Career Scientists

CDA founded 30 years ago as one of the few private sources of funding aimed specifically at early-career vision researchers.

Read More

 

Could An Eye Exam Reveal Alzheimer’s Disease?

Study from RPB-supported researchers at Duke University suggests loss of blood vessels in retina reflect changes in brain health.

Read More

 

New Findings on Blood Vessel Regulation

A study from an RPB-supported researcher at Northwestern University School of Medicine could speed up the diagnosis of retinal diseases.

Read More

 

RPB-SUPPORTED RESEARCHERS INTEGRAL TO NEI’S AUDACIOUS GOALS INITIATIVE

Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.